Microbio was honoured to deliver a presentation and two posters at the American Society for Microbiology (ASM) flagship annual meeting, Microbe. ASM Microbe is one of the world’s largest microbial science meetings and was held in Houston, Texas 15-19 June 2023. Abstract presentation Microbio’s Chief Scientific Officer, Dr Flavia Huygens presented in Session ID023: Getting… Continue reading Microbio presents at ASM Microbe 23
23 May 2023 For Immediate Release Statement From Microbio Microbio chair Mary Harney today announced the appointment of a new interim CEO following the decision of founding CEO and shareholder Paul Carboon to step away from the role. Harney said that Colin Keating would assume the role on an interim basis while the search for… Continue reading Statement from Microbio Ltd Board
Microbio presented two posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Copenhagen 15-18 April 2023. This year’s conference attracted 14,500 in-person delegates and provided Microbio’s representatives with the opportunity to promote InfectID-BSI and its potential to inform timely management of bloodstream infections and sepsis.
Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target
Brisbane based biotech scale-up, Microbio, is set to take on new local and international markets after gaining International Organisations for Standardisation (ISO) 13485:2016 Certification for its quality management system. Read more in the media release: 221115 ISO Certification opens new markets for Microbio